List of benzimidazole opioids explained

Benzimidazole opioids, also known as nitazenes, are a class of synthetic opioids with an unusual benzimidazole structure often referred to as "opioid New Psychoactive Substances", or "opioid NPS".[1] [2]

First synthesized in the 1950s by CIBA Pharmaceuticals as potential analgesic medications, several substances in the class have been identified, the best known being etonitazene.[3] Like other synthetic opioids, benzimidazole opioids bind the mu-opioid receptor and may exhibit potency up to several hundred times that of morphine.[4] [5] [6] [7] [8] While several substances in this class have found applications in research, they have never been used in clinical medicine due to their profound risk of respiratory depression and death.[9]

In the early 2020s, the substance has been recognized as emerging drugs of abuse.[10] [11] [12] Isotonitazene was first identified in samples of illicit drugs, and implicated in opioid overdose deaths in Europe, Canada, and the United States beginning in 2019.[13] Previously known nitazene analogs such as metonitazene and butonitazene, as well as novel nitazenes not previously described in the scientific or patent literature, have since been discovered in toxicologic samples during forensic investigations. Nitazene analogs have been found in pills missold as other drugs, such as benzodiazepines, in the United Kingdom[14] and New Zealand.[15]

Structure-activity relationship

The structure-activity relationship of the drug class has been explored to a reasonable extent. The optimal substitution pattern is fairly tightly defined (i.e. N,N-diethyl on the amine nitrogen, 4-ethoxy on the benzyl ring and 5-nitro on the benzimidazole ring), but even derivatives incorporating only some of these features are still potent opioids. If a methyl or carboxamide group is added on the alpha carbon of the benzyl group, or the benzyl is replaced by 2-phenylethyl, compounds of similar activity are obtained. Relative analgesic activity values are derived from tests on mice and cannot be extrapolated directly to humans, though the same general activity trends apply.[16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26]

A 2019 publication[27] has shown the possibility the previously assumed binding position of the benzimidazole class,[28] acting as a semi-rigid fentanyl analogue may be incorrect. Based on a large scale analysis of known opioid receptor ligands a template was created through manual overlaying and alignment which has identified several mu-specific areas within the receptor. In this analysis, it is noted, etonitazene now more closely matches another, separate mu-specific region, sharing only a small area in common with the fentanyl class.

Abuse

In the UK, abuse of nitazene analogues emerged in 2023 as an important cause of drug-overdose death, with it being linked to 54 deaths over a 6-month period.[29] Most of the deaths have occurred outside London, the source of supply is thought to be by post from laboratories in China and some of the deaths have been associated by the mislabelling of nitazenes as fentanyl. While compounds from this class are sometimes incorrectly referred to as "nitazene",[30] the 4 unsubstituted compound nitazene itself is of relatively low potency and has not been reported as a designer drug, with most cases of abuse and overdose linked to more potent derivatives such as metonitazene, protonitazene, isotonitazene, etonitazepyne and etodesnitazene.

Table of benzimidazole opioids

Chemical structure Drug nameRing substitutionAnalgesic potency (morphine = 1)PubChemCAS number
Desnitazene (1-diethylaminoethyl-2-benzyl-benzimidazole)hydrogen0.12878717817-67-3
Metodesnitazene (Metazene)4-methoxy12641214030-77-4
1071546-40-1 (HCl)
Metodesnitazepyne4-methoxy
Etodesnitazene (Etazene)4-ethoxy7014979738614030-76-3
Etodesnitazepyne4-ethoxy20162623599
Etodesnitazepipne4-ethoxy10162623611102762-98-1
Protodesnitazene4-(n-propoxy)10157010653805212-21-9
Isotodesnitazene4-isopropoxy~751626237082732926-27-9
Nitazenehydrogen21532752414030-71-8
Ethylene nitazenehydrogen15327525
meta-Metonitazene3-methoxy2
Metonitazene4-methoxy1005331636614680-51-4
Metonitazepyne4-methoxy
Metonitazepipne4-methoxy
N-Desethylmetonitazene4-methoxy
Metomethazene4-methoxy
Dimetonitazene3,4-dimethoxy1016262383695809-33-9
α-methyl-metonitazene4-methoxy50162625089806634-80-0
α-methyl-etonitazene4-ethoxy
α-hydroxy-etonitazene4-ethoxy21815907
Metonitazene phenethyl homologue (Ethylene metonitazene)4-methoxy50
Ethylene etonitazene4-ethoxy
Etonitazene4-ethoxy1000-150013493911-65-9
O-Desethyl-etonitazene4-hydroxy115658896994758-81-3
N-Desethyletonitazene (NDE)4-ethoxy1000/1500-20001626235802732926-26-8
Etonitazene 5-amino metabolite4-ethoxy213408927
Etomethazene4-ethoxy2016831044695293-25-7
Etonitazene 5-trifluoromethyl analogue (Etotriflazene)[31] 4-ethoxy21815908
5-Trifluoromethyl isotodesnitazene4-isopropoxy
Etonitazene 5-cyano analogue (Etocyanazene) [32] 4-ethoxy2726815419-87-1
Etonitazene 5-acetyl analogue (Etoacetazene) [33] 4-ethoxy2595713406-60-5
Etonitazene 5,6-dichloro analogue (Etodicloazene)4-ethoxy
Etonitazene N,N-dimethyl analogue4-ethoxy2067089584714190-52-0
Etonitazepyne4-ethoxy180-1901558047602785346-75-8
Etonitazepipne4-ethoxy190 [34] 162623834734496-28-7
Etonitazene morpholine analogue4-ethoxy2162623685805958-08-1
1-Ethyl pyrrolidinylmethyl N-desalkyl etonitazene4-ethoxy
Etonitazene 6-nitro isomer (iso-etonitazene) [35] 4-ethoxy2059799752114160-61-1
Protonitazene4-(n-propoxy)200156589001119276-01-6
95958-84-2
Protonitazepyne4-(n-propoxy)180-190168322728
Protonitazepipne4-(n-propoxy)
N-Desethylprotonitazene4-(n-propoxy)
Isotonitazene4-isopropoxy50014572197914188-81-9
Isotonitazepyne4-isopropoxy168322631
Isotonitazepipne4-isopropoxy
N-Desethylisotonitazene4-isopropoxy1000-20001626238992732926-24-6
iso-isotonitazene4-isopropoxy
Butonitazene4-butoxy515658895595810-54-1
Isobutonitazene4-isobutoxy168322282
Secbutonitazene4-secbutoxy168322285
Etoetonitazene4-ethoxyethoxy50162623504806642-21-7
Fluornitrazene [36] 4-(2-fluoroethoxy)172332078
Trifluorometonitazene4-trifluoromethoxy
Flunitazene4-fluoro11565889672728-91-8
Clonitazene4-chloro3625283861-76-5
Diclonitazene2,4-dichloro
α-carboxamido-clonitazene4-chloro3
Bronitazene4-bromo5162623726
Nitronitazene4-nitro
Methylnitazene (Menitazene)4-methyl1016262368395282-00-1
Ethylnitazene (Enitazene)4-ethyl20162623845114160-82-6
Propylnitazene (Pronitazene)4-propyl50162623877700342-00-3
t-Butylnitazene4-(tert-butyl)2162623621805215-64-9
Acetoxynitazene4-acetoxy5162623779102760-24-7
Methionitazene4-methylthio50162623790102471-37-4
Ethylthionitazene4-ethylthio30162623931102758-70-3
Etodesnitazene phenylthio analogue4-ethoxy1210453275-92-1
Etodesnitazene phenylthio / pyrrolidine analogue4-ethoxy21984649913451-68-8
Methylenedioxynitazene[37] 3,4-methylenedioxy
Ethyleneoxynitazene[38] fused tetrahydrofuran

See also

Notes and References

  1. Pergolizzi Jr . Joseph . Raffa . Robert . LeQuang . Jo Ann K . Breve . Frank . Varrassi . Giustino . Old Drugs and New Challenges: A Narrative Review of Nitazenes . Cureus . 2023 . 15 . 6 . e40736 . 10.7759/cureus.40736 . free . 2168-8184 . 37485167. 10361140 .
  2. Ujváry I, Christie R, Evans-Brown M, Gallegos A, Jorge R, de Morais J, Sedefov R . DARK Classics in Chemical Neuroscience: Etonitazene and Related Benzimidazoles . ACS Chemical Neuroscience . 12 . 7 . 1072–1092 . April 2021 . 33760580 . 10.1021/acschemneuro.1c00037 . 232356192 .
  3. US . 2944062 . Certain Alpha (1-diethylaminoethyl (2), Alpha Aryl Acetamides . Hoffman K, Hunger A . Ciba Pharma Products Inc. . 5 July 1960 .
  4. Glatfelter GC, Vandeputte MM, Chen L, Walther D, Tsai MM, Shi L, Stove CP, Baumann MH . Alkoxy chain length governs the potency of 2-benzylbenzimidazole 'nitazene' opioids associated with human overdose . Psychopharmacology . 240 . 12 . 2573–2584 . December 2023 . 37658878 . 10.1007/s00213-023-06451-2 .
  5. Tsai MM, Chen L, Baumann MH, Canals M, Javitch JA, Lane JR, Shi L . In Vitro Functional Profiling of Fentanyl and Nitazene Analogs at the μ-Opioid Receptor Reveals High Efficacy for Gi Protein Signaling . ACS Chemical Neuroscience . 15 . 4 . 854–867 . February 2024 . 38345920 . 10.1021/acschemneuro.3c00750 .
  6. Kozell LB, Eshleman AJ, Wolfrum KM, Swanson TL, Bloom SH, Benware S, Schmachtenberg JL, Schutzer KA, Schutzer WE, Janowsky A, Abbas AI . Pharmacologic Characterization of Substituted Nitazenes at μ, κ, and Δ Opioid Receptors Suggests High Potential for Toxicity . The Journal of Pharmacology and Experimental Therapeutics . 389 . 2 . 219–228 . April 2024 . 38453524 . 10.1124/jpet.123.002052 . 11026150 .
  7. Kanamori T, Okada Y, Segawa H, Yamamuro T, Kuwayama K, Tsujikawa K, Iwata YT. Analysis of highly potent synthetic opioid nitazene analogs and their positional isomers. Drug Test Anal. 2023 Apr;15(4):449-457.
  8. Vandeputte MM, Glatfelter GC, Walther D, Layle NK, St Germaine DM, Ujváry I, Iula DM, Baumann MH, Stove CP. Characterization of novel nitazene recreational drugs: Insights into their risk potential from in vitro µ-opioid receptor assays and in vivo behavioral studies in mice. Pharmacol Res. 2024 Nov 7;210:107503.
  9. Montanari E, Madeo G, Pichini S, Busardò FP, Carlier J . Acute Intoxications and Fatalities Associated With Benzimidazole Opioid (Nitazene Analog) Use: A Systematic Review . Therapeutic Drug Monitoring . 44 . 4 . 494–510 . August 2022 . 35149665 . 10.1097/FTD.0000000000000970 . 246776288 .
  10. US . 2935514 . patent . BENZMDAZOLES (sic) . 1960-05-03 . 1957-09-19 . 1957-09-28 . Hoffman K, Hunger A . Ciba Pharmaceutical Products Inc..
  11. Web site: Drug Enforcement Administration. June 2021. Benzimidazole Opioids. 6 January 2022.
  12. Walton SE, Krotulski AJ, Logan BK . A Forward-Thinking Approach to Addressing the New Synthetic Opioid 2-Benzylbenzimidazole Nitazene Analogs by Liquid Chromatography-Tandem Quadrupole Mass Spectrometry (LC-QQQ-MS) . Journal of Analytical Toxicology . 46 . 3 . 221–231 . March 2022 . 34792157 . 8935987 . 10.1093/jat/bkab117 .
  13. Report on the risk assessment of N,N-diethyl-2- 4-(1-methylethoxy)phenylmethyl]-5-nitro-1Hbenzimidazole- 1-ethanamine (isotonitazene) in accordance with Article 5c of Regulation (EC) No 1920/2006 (as amended). ]. European Monitoring Centre for Drugs and Drug Addiction . 2020-11-13 . 10.2810/107576 . 9 May 2022 . Publications Office of the European Union. European Monitoring Centre for Drugs Drug Addiction . 9789294974952 .
  14. Web site: Lanes . Rick . PHILTRE Annual Report April 2022 - March 2023 . 1 July 2024 . WEDINOS.
  15. Web site: April 19, 2024 . Potent opioid found in fake diazepam . 1 July 2024 . The Level NZ.
  16. Gross F, Turrian H . [Benzimidazole derivatives with strong analgesic effects] . Experientia . 13 . 10 . 401–3 . October 1957 . 13473818 . 10.1007/BF02161117 . 6824038 .
  17. Renton P, Green B, Maddaford S, Rakhit S, Andrews JS . NOpiates: Novel Dual Action Neuronal Nitric Oxide Synthase Inhibitors with μ-Opioid Agonist Activity . ACS Medicinal Chemistry Letters . 3 . 3 . 227–31 . March 2012 . 24900459 . 4025805 . 10.1021/ml200268w .
  18. Hunger A, Kebrle J, Rossi A, Hoffmann K . [Synthesis of analgesically active benzimidazole derivatives with basic substitutions] ]. Experientia . 13 . 10 . 400–1 . October 1957 . 13473817 . 10.1007/BF02161116 . 32179439 . Synthesis of analgesically active benzimidazole derivatives with basic substitutions .
  19. Rossi A, Hunger A, Kebrle J, Hoffmann K . Benzimidazol-Derivate und verwandte Heterocyclen. IV. Die Kondensation von o-Phenylendiamin mit α-Aryl- und γ-Aryl-acetessigester. Helvetica Chimica Acta. 1960. 43. 4. 1046–1056 . 10.1002/hlca.19600430413 . Benzimidazole derivatives and related heterocycles IV. The condensation of o-phenylenediamine with α-aryl and γ-aryl-acetoacetate. de.
  20. Rossi A, Hunger A, Kebrle J, Hoffmann K . Benzimidazol-Derivate und verwandte Heterocyclen V. Die Kondensation von o-Phenylendiamin mit aliphatischen und alicyclischen β-Ketoestern. Helvetica Chimica Acta. 1960. 43. 5. 1298–1313. 10.1002/hlca.19600430515. Benzimidazole derivatives and related heterocycles V. The condensation of o-phenylenediamine with aliphatic and alicyclic β-keto esters. de.
  21. Hunger A, Kebrle J, Rossi A, Hoffmann K . Benzimidazol-Derivate und verwandte Heterocyclen VI. Synthese von Phenyl-[1-aminoalkyl-benzimidazolyl-(2)]-essigsäure-estern und -amiden]. Helvetica Chimica Acta. 1960. 43. 6. 1727–1733. 10.1002/hlca.19600430634. Benzimidazole derivatives and related Heterocycles VI. Synthesis of phenyl-[1-aminoalkyl-benzimidazolyl-(2)]-acetic acid esters and amides. de.
  22. Hunger A, Kebrle J, Rossi A, Hoffmann K . Benzimidazol-Derivate und verwandte Heterocyclen VII. Synthese neuer 2-Amino-benzimidazole. Helvetica Chimica Acta. 1961. 44. 5. 1273–1282. 10.1002/hlca.19610440513. Benzimidazole Derivatives and related Heterocycles VII. Synthesis of new 2-amino-benzimidazole. de.
  23. Gross F, Turrian H . [Benzimidazole derivatives with strong analgesic effects] ]. Experientia . 13 . 10 . 401–3 . October 1957 . 13473818 . 10.1007/BF02161117 . 6824038 . Benzimidazole derivatives with strong analgesic effects .
  24. Seki T, Sasajima M, Watanbe Y, Nakajima K . [Studies on 2-benzimidazolethiol derivatives. N. Analgesic effect and pharmacological property of 1-(2-diethylaminoethyl)-2-(p-ethoxyphenylthio)benzimidazole hydrochloride] . ja . Yakugaku Zasshi . 87 . 3 . 296–301 . March 1967 . 6069375 . 10.1248/yakushi1947.87.3_296 . free .
  25. Seki T . [Studies on 2-benzimidazolethiol derivatives. V. Structure-activity relationship on analgesic action of 1-(dialkylamino-alkyl)-2-(p-ethoxyphenylthio)benzimidazole] . ja . Yakugaku Zasshi . 87 . 3 . 301–9 . March 1967 . 6069376 . 10.1248/yakushi1947.87.3_301 . free .
  26. Seki T, Watanabe Y . [Studies on 2-benzimidazolethiol derivatives. VI. Synthesis and analgesic effect of 1-(2-diethylaminoethyl)-2-(p-ethoxyphenylthio)-5-substituted benzimidazole] . ja . Yakugaku Zasshi . 89 . 5 . 617–26 . May 1969 . 5817995 . 10.1248/yakushi1947.89.5_617 . free .
  27. Wu Z, Hruby VJ . Toward a Universal μ-Agonist Template for Template-Based Alignment Modeling of Opioid Ligands . ACS Omega . 4 . 17 . 17457–17476 . October 2019 . 31656918 . 6812133 . 10.1021/acsomega.9b02244 . free .
  28. Beckett AH, Casy AF . Analgesics and their antagonists: biochemical aspects and structure-activity relationships . Progress in Medicinal Chemistry . 4 . 171–218 . February 1965 . 5319798 . 10.1016/s0079-6468(08)70169-3 . 9780444533234 .
  29. News: Homer A, Johal N . Street drugs stronger than heroin linked to 54 deaths in UK . BBC News . 11 December 2023.
  30. https://www.afp.gov.au/news-centre/media-release/rising-imports-potent-drug-nitazene-raises-concern Rising imports of potent drug nitazene raises concern. Australian Federal Police, 5 May 2024
  31. Tonelli M, Cichero E, Mahmoud AM, Rabbito A, Tasso B, Fossa P, Ligresti A . Exploring the effectiveness of novel benzimidazoles as CB2 ligands: synthesis, biological evaluation, molecular docking studies and ADMET prediction . MedChemComm . 9 . 12 . 2045–2054 . December 2018 . 30647880 . 6301267 . 10.1039/c8md00461g .
  32. Lecolier S, Trouiller G . Nouveaux benzimidazoles doués d'activité morphinique. . New benzimidazoles with opioid activity. . French . Chim. Ther. . 1967 . 2 . 16–24 .
  33. Web site: A review of the evidence on the use and harms of 2-benzyl benzimidazole ('nitazene') and piperidine benzimidazolone ('brorphine-like') opioids. . Advisory Council on the Misuse of Drugs . UK . July 2022 .
  34. Vandeputte MM, Verougstraete N, Walther D, Glatfelter GC, Malfliet J, Baumann MH, Verstraete AG, Stove CP . First identification, chemical analysis and pharmacological characterization of N-piperidinyl etonitazene (etonitazepipne), a recent addition to the 2-benzylbenzimidazole opioid subclass . Archives of Toxicology . 96 . 6 . 1865–1880 . June 2022 . 35449307 . 10.1007/s00204-022-03294-2 . 2022ArTox..96.1865V . 1854/LU-8751259 . free .
  35. Kanamori T, Okada Y, Segawa H, Yamamuro T, Kuwayama K, Tsujikawa K, Iwata YT . Analysis of highly potent synthetic opioid nitazene analogs and their positional isomers . Drug Testing and Analysis . 15. 4. 449–457. November 2022 . 36437623 . 10.1002/dta.3415 . 254042990 .
  36. https://patentscope.wipo.int/search/docs2/pct/WO2024196438/pdf/Olcc8SsLYG_8Qznlzl4vBTUU0AMyyYhN_ChMhS1HEcs?filename=WO2024196438-PAMPH-20240926-9882.pdf Michaelides M, et al. Fluorinated Mu-Opioid Receptor Agonists. WO 2024/196438
  37. Web site: Fourth addendum to ACMD report on the use and harms of 2-benzyl benzimidazole ('nitazene') and piperidine benzimidazolone ('brorphine-like') opioids. . Advisory Council on the Misuse of Drugs . 5 April 2024 .
  38. Web site: Third addendum to ACMD report on the use and harms of 2-benzyl benzimidazole ('nitazene') and piperidine benzimidazolone ('brorphine-like') opioids. . Advisory Council on the Misuse of Drugs. . 15 December 2023 .